跳至主要内容
临床试验/NCT05304494
NCT05304494撤回不适用

Sentinel - Triaging Acute Breathlessness Using Multi-Modal Biomarkers

Sanome0 个研究点开始时间: 2022年3月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
主要终点
Physician assessed severity of breathlessness

研究概览

简要总结

The Sentinel-001 study aims to identify a combination of biomarkers suitable for triage of breathlessness.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged 18-90 years.
  • Has experienced episode of breathlessness during the past 12 months triggering interaction with a health care professional. Self-reported breathlessness using any of the following words to describe symptoms will qualify as a presentation of breathlessness regardless of aetiology or severity of symptoms: shortness of breath, tight chest, trouble breathing, breathlessness, dyspnoeic, breathless, asthmatic, suffocating, wheezing, fighting for breath or any equivalent word. Breathlessness does not have to be the primary presenting symptom.
  • Deemed clinically sufficiently stable to participate according to health care practitioner.

排除标准

  • Inability to understand written local language at a year 5 level.
  • Not being confident in use of digital technology (smartphone and/or tablet). This will become evident through an inability to use the system.
  • Inability to enter required study sample data due to diminished consciousness and/or physical or mental capacity regardless of whether this is associated with the breathlessness event.
  • Received an investigational medical product in the context of a Clinical Trial during the 28 days prior to first probe administration.

结局指标

主要结局

Physician assessed severity of breathlessness

时间窗: 1 day (One-time assessment during a participant reported episode of breathlessness)

Breathlessness requiring admission or supplementary oxygen, breathlessness requiring intervention \< 24 hours, Breathlessness requiring medical intervention within 24 hours without meeting the criteria for severe breathlessness, Breathlessness not requiring any medical intervention within 24 hours other than a dose change in the individuals pre-established pharmacological treatment plan

次要结局

未报告次要终点

研究者

发起方
Sanome
申办方类型
Industry
责任方
Sponsor

相似试验